Prognostic Heterogeneity in Intermediate-Risk Papillary Thyroid Cancer: Surgery, Radioiodine, and Reclassification Using the 2025ATA Risk Stratification System

Abstract Background The 2015 American Thyroid Association (ATA) intermediate-risk category for papillary thyroid carcinoma (PTC) includes patients with heterogeneous outcomes, creating uncertainty regarding surgical extent and postoperative radioactive iodine (RAI). This study evaluated associations of surgical extent and RAI with structural recurrence-free survival (sRFS) and assessed prognostic stratification using the 2025 ATA system. Methods We retrospectively analyzed 454 patients with PTC treated between January 2018 and December 2021 who met the 2015 ATA intermediate-risk criteria. Patients underwent lobectomy without RAI (n = 68), total thyroidectomy without RAI (n = 102), or total thyroidectomy followed by RAI (n = 284). One-to-one propensity score matching (PSM) was performed for lobectomy versus total thyroidectomy and for total thyroidectomy with versus without RAI. All patients were reclassified according to the 2025 ATA system. Results After PSM, sRFS did not differ significantly between lobectomy and total thyroidectomy (P = 0.487) or between total thyroidectomy with and without RAI (P = 0.744). Reclassification assigned 1 patient (0.2%) to low risk, 123 (27.1%) to low-intermediate risk, 322 (70.9%) to intermediate-high risk, and 8 (1.8%) to high risk. Structural event rates were 0%, 12.2%, 17.4%, and 50.0%, respectively, with significant differences across strata (log-rank P = 0.039). Conclusion The 2015 ATA intermediate-risk category showed substantial prognostic heterogeneity. Neither more extensive surgery nor postoperative RAI was associated with improved sRFS after PSM. The 2025 ATA system further separated this population into prognostically distinct groups, although treatment-specific benefits within these strata were not evaluated.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11497051/v1
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Prognostic Heterogeneity in Intermediate-Risk Papillary Thyroid Cancer: Surgery, Radioiodine, and Reclassification Using the 2025ATA Risk Stratification System

X Q Guo, 王欣欣, Keyi Lu, Hua Wei et al.
Research Square
Thyroid Cancer Diagnosis and Treatment
preprint

Prognostic Heterogeneity in Intermediate-Risk Papillary Thyroid Cancer: Surgery, Radioiodine, and Reclassification Using the 2025ATA Risk Stratification System

X Q Guo, 王欣欣, Keyi Lu, Hua Wei, Yanwen Wang, Weihua Li
preprint en

Abstract

Abstract Background The 2015 American Thyroid Association (ATA) intermediate-risk category for papillary thyroid carcinoma (PTC) includes patients with heterogeneous outcomes, creating uncertainty regarding surgical extent and postoperative radioactive iodine (RAI). This study evaluated associations of surgical extent and RAI with structural recurrence-free survival (sRFS) and assessed prognostic stratification using the 2025 ATA system. Methods We retrospectively analyzed 454 patients with PTC treated between January 2018 and December 2021 who met the 2015 ATA intermediate-risk criteria. Patients underwent lobectomy without RAI (n = 68), total thyroidectomy without RAI (n = 102), or total thyroidectomy followed by RAI (n = 284). One-to-one propensity score matching (PSM) was performed for lobectomy versus total thyroidectomy and for total thyroidectomy with versus without RAI. All patients were reclassified according to the 2025 ATA system. Results After PSM, sRFS did not differ significantly between lobectomy and total thyroidectomy (P = 0.487) or between total thyroidectomy with and without RAI (P = 0.744). Reclassification assigned 1 patient (0.2%) to low risk, 123 (27.1%) to low-intermediate risk, 322 (70.9%) to intermediate-high risk, and 8 (1.8%) to high risk. Structural event rates were 0%, 12.2%, 17.4%, and 50.0%, respectively, with significant differences across strata (log-rank P = 0.039). Conclusion The 2015 ATA intermediate-risk category showed substantial prognostic heterogeneity. Neither more extensive surgery nor postoperative RAI was associated with improved sRFS after PSM. The 2025 ATA system further separated this population into prognostically distinct groups, although treatment-specific benefits within these strata were not evaluated.

Research Square
First Hospital of Shanxi Medical University (CN)
Good health and well-being
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon